Stone » Performance Data » EuroPlus Dividend Growth Fund

Ideal for investors seeking total return tax efficient dividend income via European exposure, combining growth potential over the mid to long-term, dividend income, and lower risk than the MSCI Europe Index.

Daily Prices

Series Type Code Current NAVPS Prior NAVPS NAVPS Change Net Asset Value Last Updated
A Front SCL715 $ 12.3030 $ 12.3335 -0.25% $ 18,067,141 2017-02-24
*B DSC SCL716 $ 11.7473 $ 11.7767 -0.25% $ 312,243 2017-02-24
F Eligible SCL717 $ 13.4342 $ 13.4618 -0.20% $ 4,619,119 2017-02-24
T8A Front SCL7158 $ 5.9949 $ 6.0099 -0.25% $ 426,266 2017-02-24
L Low SCL719 $ 15.6674 $ 15.7066 -0.25% $ 7,929,498 2017-02-24
* Closed to new purchases.

Series Rolling Returns (%)

Series 1 Month 3 Month 6 Month Year To Date 1 Year 3 Year 5 Year 10 Year Since Inception
A (2.8) (3.6) (7.0) (2.8) (9.0) 1.9 9.3 n/a 2.1
Benchmark (1.0) 2.2 2.6 (1.0) 1.1 4.2 11.4 n/a 2.7
B (2.8) (3.8) (7.3) (2.8) (9.6) 1.3 8.6 n/a 1.6
Benchmark (1.0) 2.2 2.6 (1.0) 1.1 4.2 11.4 n/a 2.7
F (2.7) (3.3) (6.5) (2.7) (8.0) 2.9 10.4 n/a 3.1
Benchmark (1.0) 2.2 2.6 (1.0) 1.1 4.2 11.4 n/a 2.7
L (2.8) (3.7) (7.3) (2.8) (9.6) 1.4 8.7 n/a 8.0
Benchmark (1.0) 2.2 2.6 (1.0) 1.1 4.2 11.4 n/a 2.7
T8A (2.8) (3.6) (7.0) (2.8) (9.1) 1.8 9.2 n/a 2.0
Benchmark (1.0) 2.2 2.6 (1.0) 1.1 4.2 11.4 n/a 2.7

Calendar Returns

CALENDAR RETURN 20162015201420132012201120102009200820072006
A (10.4) 17.7 3.3 27.2 15.6 (0.1) (6.6) 13.1 (27.0)
B (11.0) 17.1 2.7 26.4 14.7 (0.2) (7.1) 12.6 (27.2)
C 2.8 26.4 14.7 (0.3) (7.1) 12.6 (27.2)
F (9.6) 19.0 4.4 28.5 16.9 0.4 (5.6) 14.1 (26.5)
T8A (10.6) 17.8 3.3 27.1 15.7 0.3 (6.7) 12.4 (27.0)
T8B 2.9 26.8 14.9 (0.2) (7.1) 12.6 (27.2)
T8C 14.7 (0.3) (7.1) 12.4 (27.2)
L (11.0) 17.2 2.8 26.6 15.0 (0.2)
Benchmark (2.8) 15.7 2.5 33.8 16.6 (9.1) (1.2) 16.7 (32.3)
Benchmark: MSCI Europe $C

Growth of $10,000 Since Inception

Portfolio Composition (%)

Top Holdings (%)

HOLDINGS
1 Novartis AG, Registered 4.7
2 Newbelco SA/NV 4.2
3 Reckitt Benckiser 4.2
4 Sampo Group 4.2
5 Provident Financial plc 4.1
6 Unilever NV 3.6
7 Henkel AG & Co. 3.6
8 Kinepolis Group NV 3.6
9 Reed Elsevier plc 3.6
10 Roche Holding AG Genusscheine 3.5
Total 39.3%

Fund Management Expense Ratio As of Dec. 31st, 2015

A B F L T8A
2.90 3.52 1.92 3.38 2.86